Earnings History Data for Talphera, Inc. (TLPH) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Talphera, Inc.
Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | TLPH | Talphera, Inc. | 15.12 | -0.13 | -0.20 | -0.08 | AcelRx Pharmaceuticals GAAP EPS of -$0.13 beats by $0.07 [11/13/2024 4:09 PM] |
0.6601 | -0.23 (-25.83%) |
0.74 | -0.15 (-16.85%) |
0.43 - 1.61 | 353,056 | 40,000 | 50,131 | ||
| 14-08-2024 | AH | TLPH | Talphera, Inc. | 16.70 | -0.15 | -0.22 | -0.41 | AcelRx Pharmaceuticals GAAP EPS of -$0.15 beats by $0.06 [8/14/2024 4:37 PM] |
0.8844 | 0.02 (2.84%) |
0.95 | 0.09 (10.47%) |
0.43 - 1.61 | 18,993 | 50,000 | 1,380 | ||
| 14-05-2024 | AH | TLPH | Talphera, Inc. | 17.22 | -0.16 | -0.28 | 0.00 | AcelRx Pharmaceuticals GAAP EPS of -$0.16 beats by $0.06 [5/14/2024 4:06 PM] |
1.20 | 0.18 (17.36%) |
1.02 | 0.0 (0.00%) |
0.43 - 1.61 | 489,279 | 50,000 | 7,291 | ||
| 06-03-2024 | AH | TLPH | Talphera, Inc. | 22.21 | -0.25 | -0.24 | 1.00 | AcelRx Pharmaceuticals GAAP EPS of -$0.25, revenue of $0.3M [3/6/2024 4:33 PM] |
1.15 | -0.12 (-9.84%) |
1.29 | 0.02 (1.57%) |
0.43 - 1.61 | 163,508 | 110,000 | 928 | ||